Mark Eisner Vir Biotechnology, Inc. (VIR) insider trading activity
Mark Eisner is EVP and Chief Medical Officer of Vir Biotechnology, Inc.. Currently has a direct ownership of 75,000 shares of VIR, which is worth approximately $550,500. The most recent transaction as insider was on Jul 15, 2024, when has been sold 75,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
75K
0%
3M change
n/a
12M change
Total Value Held
$550,500
Mark Eisner Transaction History
Also insider at
ME
Mark Eisner
EVP and Chief Medical Officer
San Francisco, CA